GLYCOPATH
GlycoPath is creating innovative solutions to roadblocks in biomarker discovery and clinical assay development.
GLYCOPATH
Industry:
Biotechnology Clinical Trials Medical
Founded:
2019-01-01
Address:
Charleston, South Carolina, United States
Country:
United States
Website Url:
http://www.glycopath.com
Status:
Active
Total Funding:
0
Similar Organizations
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Investors List
National Cancer Institute
National Cancer Institute investment in Grant - GlycoPath
Official Site Inspections
http://www.glycopath.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "GlycoPath"
GlycoPath Inc.
Glycopath is now part of bruker glycobiology solutions. Learn More. Customers interested in the GlycoPath kit for released glycan spatial biology imaging, please contact glycopath@bruker.com . Back to Top. Bruker Glycobiology …See details»
GlycoPath - Crunchbase Company Profile & Funding
When was the last funding round for GlycoPath? GlycoPath closed its last funding round on Mar 7, 2022 from a Grant round. Who are GlycoPath 's competitors? Alternatives and possible …See details»
GlycoPath Inc - LinkedIn
At GlycoPath, our mission is to generate new applications utilizing MALDI Mass Spectrometry Imaging to study changes in the glycosylation of various disease states. By generating …See details»
GlycoPath Company Profile 2025: Valuation, Funding & Investors
GlycoPath General Information Description. Developer of advanced bioanalytical assays intended for the detection of liver fibrosis. The company's glycan profiling technology captures …See details»
GlycoPath Company Profile | Management and Employees List
GlycoPath Profile and History. GlycoPath Inc. is a Biotech company that generates new applications utilizing MALDI Mass Spectrometry Imaging to study changes in the glycosylation …See details»
GlycoPath, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Jul 9, 2023 Explore GlycoPath, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news.See details»
GlycoPath Inc Overview | SignalHire Company Profile
At GlycoPath, our mission is to generate new applications utilizing MALDI Mass Spectrometry Imaging to study changes in the glycosylation of various disease states. ... Organization …See details»
GlycoPath - Overview, News & Similar companies | ZoomInfo.com
GlycoPath Inc. is a Biotech company that generates new applications utilizing MALDI Mass Spectrometry Imaging to study changes in the glycosylation of various disease states. It offers …See details»
GlycoPath - Org Chart, Teams, Culture & Jobs - The Org
View GlycoPath's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
GlycoPath - Funding, Financials, Valuation & Investors - Crunchbase
Mar 7, 2022 GlycoPath creates solutions to roadblocks in biomarker discovery and clinical assay development. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How …See details»
GlycoPath - Products, Competitors, Financials, Employees, …
GlycoPath focuses on the development of clinical glycomic assays within the biotechnology sector. The company offers the GlycoTyper assay for protein-specific glycan analysis and the …See details»
GlycoPath - Crunchbase
GlycoPath creates solutions to roadblocks in biomarker discovery and clinical assay development.See details»
Leadership Team - GlycoPath Inc.
Glycopath, 22 WestEdge St - Suite 400, Charleston, SC 29403, United States ...See details»
GlycoPath, LLC - VentureRadar
GlycoPath, LLC VentureRadar profile. Find out more about GlycoPath, LLC including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
GlycoPath Appoints Kathy Phlegar as CEO — GlycoPath Inc.
Feb 15, 2023 GlycoPath Inc. has appointed Kathy Phlegar as CEO. This change comes as the company continues to drive towards commercialization of its proprietary assays. Kathy …See details»
GlycoPath: Revenue, Competitors, Alternatives - Growjo
At GlycoPath, our mission is to generate new applications utilizing MALDI Mass Spectrometry Imaging to study changes in the glycosylation of various disease states. By generating …See details»
GlycoPath - Contacts, Employees, Board Members, Advisors
GlycoPath creates solutions to roadblocks in biomarker discovery and clinical assay development.See details»
GlycoPath Inc. Secures Seed Investment to Further Develop
Mar 10, 2021 GlycoPath Inc. is a developer of GlycoTyper-based bioanalytical assays using the Company's proprietary platform technology, developed at the Medical University of South …See details»
GlycoPath | CipherBio
Explore GlycoPath's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
GlycoPath Inc. Secures Seed Investment — GlycoPath Inc.
Mar 10, 2021 GlycoPath Inc. is a developer of GlycoTyper-based bioanalytical assays using the Company’s proprietary platform technology, developed at the Medical University of South …See details»